Our analysis illustrated that non-silent protein-coding mutation profiles distributed across ESCC cell lines and patient tissues are heterogeneous and diverse, with TP53, TTN, KMT2D, CSMD3, DNAH5, MUC16, and DST being the most frequently mutated genes. This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.